Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pupil Dilation in Horner's Patients Taking Flomax
NCT03615508Phase 4Terminated
- Sponsor
- Denver Health
- Start
- Sep 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of phenylephrine, sponsored by Denver Health. Primary endpoint: Pupil Size Measurements. Started Sep 2018; status: terminated.
02
Drugs
phenylephrine
Beyond the preview
Go deeper on NCT03615508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615508.